HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $609,000 | -3.8% | 14,265 | -39.6% | 0.05% | -24.6% |
| Q2 2020 | $633,000 | -83.9% | 23,622 | -89.3% | 0.06% | -45.4% |
| Q4 2019 | $3,928,000 | +1529.9% | 221,558 | +1565.8% | 0.12% | +1387.5% |
| Q3 2018 | $241,000 | -74.5% | 13,300 | -72.5% | 0.01% | -50.0% |
| Q1 2018 | $946,000 | -66.2% | 48,300 | -65.0% | 0.02% | -61.0% |
| Q4 2017 | $2,797,000 | +732.4% | 138,100 | +305.0% | 0.04% | +412.5% |
| Q4 2016 | $336,000 | +1.2% | 34,100 | +24.0% | 0.01% | -27.3% |
| Q3 2016 | $332,000 | -34.4% | 27,500 | -53.2% | 0.01% | -54.2% |
| Q2 2016 | $506,000 | -10.0% | 58,700 | -1.2% | 0.02% | -11.1% |
| Q1 2016 | $562,000 | +15.2% | 59,400 | +63.2% | 0.03% | -27.0% |
| Q3 2015 | $488,000 | +82.1% | 36,400 | +93.6% | 0.04% | +42.3% |
| Q1 2015 | $268,000 | +49.7% | 18,800 | +1.1% | 0.03% | -7.1% |
| Q4 2014 | $179,000 | – | 18,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |